AAA announces completion of EUR40 million capital increase
Advanced Accelerator Applications (AAA), an international leader in diagnostic nuclear medicine, has completed a capital increase of EUR40 million, which will help fund expansion plans and finance clinical trials of its promising portfolio of Radio Metabolic Therapy and diagnostic products. The fundraising was subscribed by existing and new shareholders,

